We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Hibiscus sabdariffa (Roselle)
Anthocyanin-rich tropical plant with well-documented antihypertensive effects, lipid-lowering properties, and emerging benefits for metabolic health and antioxidant status.
What the evidence says
Most Hibiscus studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from high-quality meta-analyses and randomised trials published 2004–2026 with a typical study size of 60 participants.
Based on 56 studies · 9 meta-analyses · 36 RCTs · 289 total participants
Confidence
High confidenceBy outcome
Scores moderate because multiple meta-analyses consistently show a modest 5-7 mmHg systolic blood-pressure reduction, but trial quality is generally low, a Cochrane review rated evidence insufficient, and lipid effects are contradictory.
50 rigorous studies
37 randomized trials · 9 meta-analyses · 13 systematic reviews
Our evidence rating for Hibiscus is accountable to this entire body of rigorous research indexed in PubMed — not a hand-picked subset.
PubMed · as of Jul 2026
5 trials ongoing or recruiting · 25 completed on ClinicalTrials.gov
Registered trials show research momentum for Hibiscus, not proof of effect — a registration is a plan, and posted results are sponsor-reported, not peer-reviewed. They are never counted toward the evidence rating above.
Browse these trials on ClinicalTrials.govClinicalTrials.gov · as of Sep 2026
Hibiscus sabdariffa (roselle, sour tea) is a Malvaceae plant whose dried calyces are rich in anthocyanins, organic acids, and polyphenols.
Its best-supported effect is a modest reduction in blood pressure (roughly 5-7 mmHg systolic) in people with elevated or mildly high blood pressure, seen across several meta-analyses — though trial quality is generally low-to-moderate, the highest-certainty review (Cochrane) rated the evidence insufficient, and a head-to-head trial found hibiscus significantly less effective than lisinopril.
Lipid evidence is contradictory (some meta-analyses positive, others null), and glycemic effects are small. Proposed mechanisms include mild ACE inhibition, natriuretic/diuretic action, and nitric-oxide-mediated vasodilation.
It is usually taken as a brewed tisane or standardized extract, with the clearest benefit in those with higher baseline blood pressure. It is not a substitute for antihypertensive medication.
Hibiscus anthocyanins inhibit angiotensin-converting enzyme (ACE), reducing angiotensin II production and promoting vasodilation. Studies using the renin-angiotensin-aldosterone system (RAAS) markers have confirmed this mechanism in hypertensive patients (PMID:26600645). This accounts for blood pressure reductions comparable to low-dose lisinopril and captopril in clinical trials.
Hibiscus calyces contain high concentrations of anthocyanins and phenolic acids that scavenge reactive oxygen species (ROS) and upregulate endogenous antioxidant enzymes. Human pharmacokinetic data confirm rapid absorption of anthocyanidin-3-glycosides within 2 hours of consumption (PMID:15647413), with measurable increases in systemic antioxidant capacity (PMID:22331521).
Hibiscus polyphenols reduce hepatic lipogenesis, inhibit LDL oxidation, and modestly reduce circulating LDL and total cholesterol. Meta-analyses confirm significant reductions in LDL cholesterol versus placebo and other teas (PMID:34927694). Hibiscus acid and hydroxycitric acid may also inhibit ATP-citrate lyase, reducing fatty acid synthesis.
Hibiscus polyphenols suppress NF-κB signaling, reduce monocyte chemoattractant protein-1 (MCP-1) production, and modulate pro-inflammatory cytokine profiles. A clinical trial confirmed that hibiscus calyx extract significantly reduced MCP-1 in healthy humans (PMID:19765963), while immunomodulatory effects have been reviewed systematically (PMID:34040600).
Hibiscus inhibits α-glucosidase and α-amylase activity, slowing carbohydrate absorption and reducing postprandial glucose excursions. Systemic meta-analysis confirms a significant reduction in fasting plasma glucose (−3.67 mg/dL) with regular consumption (PMID:31943427). Antidiabetic effects have been documented in type 2 diabetic populations (PMID:32156406).
How Hibiscus works — from molecular targets to health outcomes. Click an edge to see supporting research.This visualization is in beta — pathways are being refined and expanded.
Avoid therapeutic doses during pregnancy. Hibiscus has demonstrated emmenagogue (uterine-stimulating) effects in animal studies and traditional use; insufficient human safety data. One RCT used a combination including hibiscus for UTI prevention in premature rupture of membranes but this requires medical supervision (PMID:41500088).
Insufficient safety data; avoid high-dose supplementation. Occasional culinary use likely safe.
Limited data in pediatric populations; therapeutic use not recommended without medical supervision.
May be appropriate with monitoring; increased sensitivity to hypotensive effects. Monitor BP and electrolytes due to mild diuretic action.
Use with caution. One RCT showed no significant adverse renal effects at standard doses (PMID:27221151), but diuretic effects and drug interactions warrant monitoring.
High interaction risk — additive BP lowering may cause symptomatic hypotension. Consult physician before use.
Hibiscus acid may chelate dietary non-heme iron. Separate hibiscus from iron-rich meals or iron supplements by at least 2 hours.
Additive blood pressure-lowering effect may cause hypotension. Monitor BP closely and adjust medication under medical supervision.
Hibiscus may reduce simvastatin exposure (increased clearance), potentially lowering its effect; monitor.
Hibiscus may increase the elimination of diclofenac and acetaminophen, potentially reducing their levels.
In vitro data suggest hibiscus calyx extracts modulate CYP1A2 activity, which metabolizes caffeine. Clinical significance at normal doses is likely low (PMID:30951501).
Tip: Take with food; reduce dose if symptoms persist
Tip: Monitor blood pressure; avoid combining with antihypertensive medications without supervision
Tip: Usually transient; reduce dose or discontinue if persistent
Tip: Discontinue immediately; seek medical attention for severe reactions
Tip: Normal physiological response; ensure adequate fluid intake
Hibiscus has an evidence score of 6/10 — moderate evidence based on 46 indexed studies, including 8 meta-analyses. Anthocyanin-rich tropical plant with well-documented antihypertensive effects, lipid-lowering properties, and emerging benefits for metabolic health and antioxidant status. Representative study: PMID 39870328.
The commonly studied dose of Hibiscus is 250–450 mg standardized extract OR 1.25–2.5 g dried calyx per serving (as tea). Individual needs vary — start at the lower end of the range and adjust based on how you respond.
The best time to take Hibiscus is with meals. Take it with food. Hibiscus anthocyanins are water-soluble and well-absorbed with or without food, but taking with meals reduces the likelihood of GI discomfort.
Hibiscus is generally safe at recommended doses, with a few precautions worth noting. Reported side effects are uncommon and include gastrointestinal discomfort (nausea, loose stools), increased urination (diuretic effect), hypotension. Use caution if any of these apply to you: Hypotension or concurrent antihypertensive medication (additive BP-lowering risk); Allergy to Hibiscus or Malvaceae family plants; Iron-deficiency anemia (may inhibit non-heme iron absorption).
Cinnamon
Mostly mechanism / observationalA polyphenol-rich spice studied mainly for modest improvements in blood sugar and blood lipids; choose Ceylon to limit coumarin.
Bergamot
Likely helpsCitrus extract studied for cholesterol management — several positive trials on LDL and triglycerides, though evidence is mixed.
Fenugreek
Likely helpsTraditional herb with evidence for supporting testosterone, libido, blood sugar control, and lactation.
Berberine
Likely helpsActivates AMPK to regulate blood sugar, improve insulin sensitivity, and support lipid metabolism — comparable to metformin in some trials.
Explore: Best supplements for Vitality & Longevity
Reviewed by Dr. Baher Al Hakim · Last reviewed June 2026 · evidence from 56 studies · how we score · editorial policy
This information is for educational purposes only. It is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication.
Tap node to isolate • Pinch to zoom • Tap edge for research